Yu-Cheng Kuo Selected Research

NF-kappa B (NF-kB)

1/2023	Therapeutic potential of EGFR/mTOR/Nf-kb targeting small molecule for the treatment of non-small cell lung cancer.
1/2022	Revealing the suppressive role of protein kinase C delta and p38 mitogen-activated protein kinase (MAPK)/NF-κB axis associates with lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Cheng Kuo Research Topics

Disease

23	Neoplasms (Cancer) 10/2023 - 03/2005
13	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 03/2005
4	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2022
4	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2018
3	Body Weight (Weight, Body) 02/2023 - 01/2018
3	Neuroinflammatory Diseases 03/2019 - 11/2014
2	Glioblastoma (Glioblastoma Multiforme) 10/2023 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 01/2023
2	Squamous Cell Carcinoma of Head and Neck 06/2023 - 01/2010
2	Disease Progression 01/2023 - 03/2019
2	Carcinogenesis 10/2021 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 02/2012
2	Liver Neoplasms (Liver Cancer) 12/2016 - 04/2014
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2015 - 03/2005
1	Dyslipidemias (Dyslipidemia) 02/2023
1	Diabetes Complications 02/2023
1	Hyperglycemia 02/2023
1	Glioma (Gliomas) 01/2023
1	Renal Insufficiency (Renal Failure) 01/2023
1	Diabetes Mellitus 01/2023
1	Adenocarcinoma 02/2022
1	Rectal Neoplasms (Rectal Cancer) 02/2022
1	Infections 01/2022
1	COVID-19 01/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Cholangiocarcinoma 10/2021
1	Brain Neoplasms (Brain Tumor) 04/2021
1	Ischemia 03/2019
1	Glaucoma 03/2019

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2017
5	amentoflavoneIBA 05/2022 - 09/2017
5	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 02/2012
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 02/2012
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021 - 01/2018
2	Temozolomide (Temodar)FDA LinkGeneric 10/2023 - 01/2023
2	Cyclin D1IBA 01/2023 - 01/2017
2	NF-kappa B (NF-kB)IBA 01/2023 - 01/2022
2	lenvatinibIBA 05/2022 - 01/2022
2	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2021
2	regorafenibIBA 01/2022 - 01/2018
2	Neuroprotective AgentsIBA 01/2019 - 01/2013
2	thiazolyl blueIBA 05/2018 - 01/2017
1	GoldIBA 10/2023
1	Bevacizumab (Avastin)FDA Link 07/2023
1	Monoclonal AntibodiesIBA 07/2023
1	Cisplatin (Platino)FDA LinkGeneric 06/2023
1	CreatinineIBA 02/2023
1	2-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA 02/2023
1	oxidized low density lipoproteinIBA 02/2023
1	Alanine (L-Alanine)FDA Link 02/2023
1	Alanine Transaminase (SGPT)IBA 02/2023
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 02/2023
1	AntioxidantsIBA 02/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2023
1	Blood Glucose (Blood Sugar)IBA 02/2023
1	CholesterolIBA 02/2023
1	Uric Acid (Urate)IBA 02/2023
1	Urea (Carbamide)FDA LinkGeneric 02/2023
1	Triglycerides (Triacylglycerol)IBA 02/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2023
1	Insulin (Novolin)FDA Link 02/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2023
1	NitrogenIBA 02/2023
1	HDL LipoproteinsIBA 02/2023
1	LDL CholesterolIBA 02/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	CateninsIBA 01/2023
1	IsotopesIBA 01/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2022
1	QuinolonesIBA 01/2022
1	Protein Kinase C-deltaIBA 01/2022
1	Genetic Markers (Genetic Marker)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 09/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Cell Cycle ProteinsIBA 01/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2021
1	DNA TopoisomerasesIBA 01/2021
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2021
1	astragaloside AIBA 03/2020
1	CytokinesIBA 03/2019
1	2,3,7,7a- tetrahydro- 3- hydroxy- 7- methyl- 2- (prop- 1- en- 1- yl)- 5H- furo(3,4- b)pyran- 5- oneIBA 03/2019
1	Retinaldehyde (Retinal)IBA 03/2019

Therapy/Procedure

10	Therapeutics 10/2023 - 12/2006
8	Radiotherapy 02/2022 - 03/2005
4	Drug Therapy (Chemotherapy) 07/2023 - 01/2021
3	Chemoradiotherapy 10/2023 - 01/2022
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2013 - 12/2006
2	Surgical Instruments (Clip) 12/2016 - 04/2014
1	Oral Administration 10/2023
1	Sphygmomanometers 01/2023
1	Esophagectomy 01/2022
1	Boron Neutron Capture Therapy 04/2021
1	Image-Guided Radiotherapy 01/2021
1	Adjuvant Radiotherapy 01/2021